 |
 | Services
| |
 |
Aliases & Descriptions for APOE
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| AD2 2, 5 | | Apo-E 3 | | LDLCQ5 2, 5 | | LPG 2, 5 | | MGC1571 2 |
| | | Descriptions |
|---|
| Alzheimer disease 2 (APOE*E4-associated, late onset) 1 | | apolipoprotein E 2 | | apolipoprotein E3 2 |
|
| | Search outside databases for aliases for APOE genePrevious GC identifers: GC19P046053 GC19P045799 GC19P050085 |
Summaries for APOE(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for APOE: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq] UniProtKB/Swiss-Prot: APOE_HUMAN, P02649Function: Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissuesGene Wiki entry for APOE (Apolipoprotein_E) |
Genomic Location for APOE
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the APOE gene 
Entrez Gene cytogenetic band: 19q13.2 Ensembl cytogenetic band: 19q13.32 HGNC cytogenetic band: 19q13.31APOE Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 19 GeneLoc Exon Structure GeneLoc location for GC19P050100:
(about GC identifiers)
Start:
|
50,100,879 bp from pter |
End:
|
50,104,490 bp from pter |
Size:
|
3,612 bases |
Orientation:
|
plus strand |
RefSeq DNA sequence:- NC_000019.8 NT_011109.15
| Proteins for APOE
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: APOE_HUMAN, P02649 (See
protein sequence)Recommended Name: Apolipoprotein E precursor Size: 317 amino acids; 36154 Da
Subcellular location: Secreted
PDB structures from and Proteopedia :1B68 (3D)
 1BZ4 (3D)
 1EA8 (3D)
 1GS9 (3D)
 1H7I (3D)
 1LE2 (3D)
 1LE4 (3D)
 1LPE (3D)
 1NFN (3D)
 1NFO (3D)
 1OEF (3D)
 1OEG (3D)
 1OR2 (3D)
 1OR3 (3D)
 2KC3 (3D)
 
Secondary accessions: B2RC15 Q9P2S4Post-translational modifications:
Synthesized with the sialic acid attached by O-glycosidic linkage and is subsequently desialylated in plasma1
Glycated in plasma VLDL of normal subjects, and of hyperglycemic diabetic patients at a higher level (2-3 fold)1
View phosphorylation sites using PhosphoSite2
REFSEQ proteins: NP_000032.1
ENSEMBL proteins: ENSP00000252486
Human Recombinant Proteins               OriGene Purified Recombinant Human Protein: APOE 
5/13 Gene Ontology (GO) cellular component terms (links to tree view) (see all 13
): About this table
Antibodies for APOE: Assays for APOE: | Protein
Domains/ Families for APOE(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P02649
ProtoNet protein and cluster: P02649 1 Blocks protein family: IPB000074 Apolipoprotein A1/A4/E
UniProtKB/Swiss-Prot: APOE_HUMAN, P02649Similarity: Belongs to the apolipoprotein A1/A4/E family | Gene Function for APOE
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000041
Applied Biosystems Silencer® siRNAs for APOE
Sigma-Aldrich siRNA and siRNA Panels for APOE  Sigma-Aldrich shRNA Panels and shRNA for APOE  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_000041                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000041                                  untagged cDNA clone in CMV expression vector: NM_000041 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_000041
UniProtKB/Swiss-Prot: APOE_HUMAN, P02649Function: Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissuesGenatlas biochemistry entry for APOE:apolipoprotein E,component of VLDL and ApoE receptors,putative susceptibility factor (epsilon 4 allele) for agressive multiple sclerosis and for early-onset coronary heart disease15/26 MGI mutant phenotypes (inferred from 13 alleles ) (MGI details for Apoe) (see all 26
):
5/12 Gene Ontology (GO) molecular function terms (links to tree view) (see all 12
): About this table | Pathways & Interactions for APOE
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
4 Sigma-Aldrich "Your Favorite Gene" Pathways for APOE (Your Favorite Gene powered by Ingenuity) 
Gene Network CentralTM Interacting Genes and Proteins Network for APOE 
5/110 Interacting proteins for APOE (ENSP000002524863) via UniProtKB, MINT, and/or STRING (see all 110
)About this table
5/44 Gene Ontology (GO) biological process terms (links to tree view) (see all 44
): About this table
|
Drugs & Compounds for APOE(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Browse Tocris compounds for APOE 10/18 Novoseek chemical compound relationships for APOE gene (see all 18
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| cholesterol |
88.63 |
2090 |
9541497 (7), 11369802 (7), 10484608 (7), 16185081 (7) (see all 99) |
| lipid |
82.16 |
1443 |
15264189 (6), 16295048 (5), 10693931 (5), 15487712 (5) (see all 99) |
| 24s-hydroxy-cholesterol |
67.04 |
24 |
15975088 (4), 17822846 (4), 16524875 (3), 12707064 (2) (see all 10) |
| xbai |
59.82 |
34 |
9298741 (2), 16699281 (2), 15543563 (2), 8013886 (2) (see all 23) |
| cholesterol ester |
58.16 |
32 |
8420942 (3), 10870678 (3), 15955471 (2), 12919138 (2) (see all 16) |
| phospholipid |
53.68 |
136 |
1730636 (4), 8908157 (4), 19159618 (3), 1540589 (3) (see all 71) |
| lathosterol |
52.16 |
5 |
8548414 (1), 11726725 (1), 15331430 (1), 1865824 (1) |
| dimyristoylphosphatidylcholine |
51.88 |
33 |
12633731 (3), 10751422 (2), 12364553 (2), 2026270 (1) (see all 11) |
| homocysteine |
50.27 |
95 |
17764386 (6), 17243563 (3), 18023533 (2), 17420762 (2) (see all 41) |
| sterol |
49.60 |
74 |
10760464 (5), 16254198 (5), 11893773 (5), 11742879 (5) (see all 26) |
About this table
10/10 PharmGKB drug compound relationships for APOE gene (see all 10
)About this table
|
Transcripts for APOE(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000041
Sigma-Aldrich siRNA and siRNA Panels for APOE  Sigma-Aldrich shRNA Panels and shRNA for APOE  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_000041 REFSEQ mRNAs for APOE gene: NM_000041.2
Applied Biosystems TaqMan ® Gene Expression Assays: NM_000041               OriGene GFP tagged cDNA clone in CMV expression vector: NM_000041                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000041                                  untagged cDNA clone in CMV expression vector: NM_000041  Additional cDNA sequence: AK308546.1 AK314898.1 BC003557.1 K00396.1 M12529.1 X00199.1 Z70760.1 23 DOTS entries: DT.100888329 DT.451248 DT.40133697 DT.97779727 DT.100888334 DT.100888336 DT.97792321 DT.91981242 DT.92463553 DT.100888335 DT.92463568 DT.92463567 DT.100888341 DT.121427095 DT.92463546 DT.95136093 DT.95136111 DT.100045379 DT.100879799 DT.100888330 DT.121121638 DT.92015941 DT.95136088 24/1484 AceView cDNA sequences (see all 1484
):AI357255 AI289184 BE223032 BF196798 AW024356 CB157579 AI819172 AI983585 AW026372 BC009698 AI359572 CB055074 BQ006785 AI359665 CA307655 BE672007 BF940051 AW005896 CB163670 CA307890 AI126876 AI096741 BQ651295 AI361165
highest scoring ESTs for APOE:AV647676 BE048819 BQ680740 R29150 M12529 AA547943 AA862728 AA863156 AA931481 AI284420 Unigene Cluster for APOE: Apolipoprotein E Hs.654439 [show with all ESTs]Unigene Representative Sequence: BQ683419
GeneLoc Exon Structure
4 Alternative Splicing Database (ASD) splice patterns (SP) for APOE
| ExUns: | 1a | · | 1b | · | 1c | · | 1d | ^ | 2a | · | 2b | · | 2c | ^ | 3 | ^ | 4a | · | 4b | · | 4c | · | 4d | |
| SP1: | |   | |   | |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   |
About this scheme
ECgene alternative splicing isoforms for APOE
1 Ensembl transcript including schematic representation: ENST00000252486
|
Expression for APOE
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| APOE expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for APOE
1 / 2 / 3 7 probe-sets matching APOE gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: CGACCCCACG
SOURCE GeneReport for Unigene cluster: Hs.654439
Expression variation in blood from EXPOLDB for APOE UniProtKB/Swiss-Prot: APOE_HUMAN, P02649Tissue specificity: Occurs in all lipoprotein fractions in plasma. It constitutes 10-20% of very low density lipoproteins (VLDL) and 1-2% of high density lipoproteins (HDL). APOE is produced in most organs. Significant quantities are produced in liver, brain, spleen, lung, adrenal, ovary, kidney and muscle |
Orthologs for APOE
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for APOE gene from 5/6 species (see all 6
)
About this table Species with no ortholog for APOE
ENSEMBL Gene Tree for APOE | Paralogs for APOE(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| -- |
SNPs/Variants for APOE(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
| UniProtKB/Swiss-Prot: APOE_HUMAN, P02649Polymorphism: Three common APOE alleles have been identified: APOE*2, APOE*3, and APOE*4. The corresponding three major isoforms, E2, E3, and E4, are recognized according to their relative position after isoelectric focusing. Different mutations causing the same migration pattern after isoelectric focusing define different isoform subtypes. The most common isoform is E3 and is present in 40-90% of the population. Common APOE variants influence lipoprotein metabolism in healthy individuals
HapMap Linkage Disequilibrium images for APOE (up to first 250kb)
|
Disorders & Mutations for APOE
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 107741 UniProtKB/Swiss-Prot: APOE_HUMAN, P02649
Defects in APOE are a cause of hyperlipoproteinemia type III [MIM:107741]; also known as familial dysbetalipoproteinemia. Individuals with hyperlipoproteinemia type III, are clinically characterized by xanthomas, yellowish lipid deposits in the palmar crease, or less specific on tendons and on elbows. The disorder rarely manifests before the third decade in men. In women, it is usually expressed only after the menopause. The vast majority of the patients are homozygous for APOE*2 alleles. More severe cases of hyperlipoproteinemia type III have also been observed in individuals heterozygous for rare APOE variants. The influence of APOE on lipid levels is often suggested to have major implications for the risk of coronary artery disease (CAD). Individuals carrying the common APOE*4 variant are at higher risk of CAD The APOE*4 allele is associated with late onset Alzheimer disease 2 (AD2) [MIM:104310]. The APOE*4 allele is genetically associated with the common late onset familial and sporadic forms of Alzheimer disease (AD). Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE*4 alleles in 42 families with late onset AD. Thus APOE*4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE*4 was virtually sufficient to cause AD by age 80. The mechanism by which APOE*4 participates in pathogenesis is not known Defects in APOE are a cause of sea-blue histiocyte disease [MIM:269600]; also called sea-blue histiocytosis. This disorder is characterized by splenomegaly, mild thrombocytopenia and, in the bone marrow, numerous histiocytes containing cytoplasmic granules which stain bright blue with the usual hematologic stains. The syndrome is the consequence of an inherited metabolic defect analogous to Gaucher disease and other sphingolipidoses Defects in APOE are a cause of lipoprotein glomerulopathy (LPG) [MIM:611771]. LPG is an uncommon kidney disease characterized by proteinuria, progressive kidney failure, and distinctive lipoprotein thrombi in glomerular capillaries. It mainly affects people of Japanese and Chinese origin. The disorder has rarely been described in Caucasians10/94 Novoseek disease relationships for APOE gene (see all 94
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| alzheimers disease |
94.93 |
2452 |
14757857 (6), 9831633 (5), 11071064 (5), 9468467 (5) (see all 99) |
| hyperlipoproteinemia type iii |
90.04 |
89 |
8175773 (4), 1730728 (3), 8185134 (3), 7772063 (3) (see all 55) |
| late onset alzheimer disease |
88.50 |
50 |
8971103 (4), 7970184 (2), 8086986 (1), 8648331 (1) (see all 32) |
| dementia |
86.18 |
631 |
9678314 (6), 12634288 (5), 9074395 (5), 17296843 (4) (see all 99) |
| senile plaques |
85.71 |
252 |
9100668 (4), 11325345 (4), 7615568 (3), 10487843 (3) (see all 99) |
| cerebral amyloid angiopathy |
82.75 |
66 |
8571412 (2), 15654038 (2), 18755411 (2), 17322072 (2) (see all 42) |
| neurofibrillary tangles |
82.26 |
127 |
10487843 (3), 9018389 (3), 9258912 (2), 2029618 (2) (see all 83) |
| atherosclerosis |
80.42 |
503 |
11369802 (5), 11007687 (5), 7593602 (5), 10933930 (5) (see all 99) |
| dementia vascular |
77.93 |
91 |
8848934 (3), 8786847 (3), 9147873 (3), 15084782 (2) (see all 53) |
| amyloid deposition |
70.62 |
54 |
17342413 (2), 8596645 (2), 11193807 (2), 11553297 (2) (see all 34) |
About this table
8 PharmGKB disease relationships for APOE geneAbout this table
Human Gene Mutation Database: APOE Genetic Association Database: APOE Human Genome Epidemiology Navigator: APOE (2110 documents)
|
Medical News for APOE(Possibly Related Articles in
Doctor's Guide)
About This Section
| |
Publications for APOE (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/4212 PubMed articles for APOE gene (see all 4212
):- Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)]. (PubMed id 11095479)1, 3, 4, 6 Nguyen T.T.... O'Brien T. (2000)
- Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease. (PubMed id 12142731)1, 3, 7 Rigaud A.S....Forette F. (2002)
- Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients. (PubMed id 12042669)3, 6, 7 Brisson D....Gaudet D. (2002)
- Analysis of association at single nucleotide polymorphisms in the APOE region. (PubMed id 10662539)2, 3, 6 Martin E.R....Vance J.M. (2000)
- Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. (PubMed id 1999275)1, 6, 7 Shriver M.D....Hanis C.L. (1991)
- Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. (PubMed id 12232782)1, 3, 6 Laws S.M....Martins R.N. (2002)
- APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. (PubMed id 15364690)1, 3, 6 Tycko B....Mayeux R. (2004)
- Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. (PubMed id 15809899)1, 3, 6 Tarr P.E....Telenti A. (2005)
- Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators. (PubMed id 15165699)1, 3, 6 Borroni B....Padovani A. (2004)
- Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction. (PubMed id 15258620)1, 3, 6 Ranjith N....Naidoo D.P. (2004)
|
Search for APOE
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing APOE
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing APOE
(According to HUGE)
About This Section
| -- |
Specialized Databases showing APOE(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| ATLAS Chromosomes in Cancer entry for APOE | Genetics and Cytogenetics in Oncology and Haematology | | GeneReviews | http://www.genetests.org/query?gene=APOE | | SHMPD | http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=APOE | | Wikipedia | http://en.wikipedia.org/wiki/Apolipoprotein_E | | Protein Spotlight | http://www.expasy.org/spotlight/back_issues/sptlt083.shtml |
|
| | | About This Section
| --
| Services for APOE(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for APOE:

 | |
 | | | | |
|
 |  |  |
| | | | Search Tocris compounds for APOE |
|
 |
 | | | |
GeneCards Homepage - Last full update: 2 Jul 2009
Incremental update: 13 Oct 2009
|